Literature DB >> 23239281

Substantia nigra echogenicity in Friedreich's ataxia patients.

María Sierra1, Jon Infante, José Berciano.   

Abstract

The aim of this study is to assess the presence of substantia nigra (SN) hypoechogenicity in a cohort of Friedreich's ataxia (FRDA) patients and its possible association with restless syndrome (RLS). Fourteen genetically confirmed FRDA patients and 14 sex- and age-matched healthy controls underwent transcranial sonography examination to evaluate the area of echogenicity of the SN. Both groups were clinically assessed with the essential and additional diagnostic criteria for RLS established by the International RLS Study Group. Ataxia was evaluated using the Scale for the Assessment and Rating of Ataxia. We did not find significant differences between the mean sum area of SN echogenicity in FRDA patients and in controls. Only one patient in the FDRA group and two control subjects showed SN hypoechogenicity. Two out of the 14 FDRA patients and one of the controls fulfilled diagnostic criteria for RLS. The areas of SN echogenicity in the two FRDA patients with RLS were the lowest found in this group. We conclude that our data do not support the notion that SN hypoechogenicity is related to FRDA itself, although it might be associated with RLS.

Entities:  

Mesh:

Year:  2013        PMID: 23239281     DOI: 10.1007/s12311-012-0434-y

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  18 in total

1.  Restless legs and substantia nigra hypoechogenicity are common features in Friedreich's ataxia.

Authors:  Matthis Synofzik; Jana Godau; Tobias Lindig; Ludger Schöls; Daniela Berg
Journal:  Cerebellum       Date:  2011-03       Impact factor: 3.847

Review 2.  Friedreich's ataxia: pathology, pathogenesis, and molecular genetics.

Authors:  Arnulf H Koeppen
Journal:  J Neurol Sci       Date:  2011-04-15       Impact factor: 3.181

3.  Transcranial sonography reveals cerebellar, nigral, and forebrain abnormalities in Friedreich's ataxia.

Authors:  Matthis Synofzik; Jana Godau; Tobias Lindig; Ludger Schöls; Daniela Berg
Journal:  Neurodegener Dis       Date:  2011-06-09       Impact factor: 2.977

4.  Increased iron in the dentate nucleus of patients with Friedrich's ataxia.

Authors:  D Waldvogel; P van Gelderen; M Hallett
Journal:  Ann Neurol       Date:  1999-07       Impact factor: 10.422

5.  Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia.

Authors:  Susan Michael; Simone V Petrocine; Jiang Qian; Jacques B Lamarche; Mitchell D Knutson; Michael D Garrick; Arnulf H Koeppen
Journal:  Cerebellum       Date:  2006       Impact factor: 3.847

6.  Clinical and genetic abnormalities in patients with Friedreich's ataxia.

Authors:  A Dürr; M Cossee; Y Agid; V Campuzano; C Mignard; C Penet; J L Mandel; A Brice; M Koenig
Journal:  N Engl J Med       Date:  1996-10-17       Impact factor: 91.245

Review 7.  Friedreich ataxia.

Authors:  Massimo Pandolfo
Journal:  Arch Neurol       Date:  2008-10

Review 8.  Diagnosis and treatment of Friedreich ataxia: a European perspective.

Authors:  Jörg B Schulz; Sylvia Boesch; Katrin Bürk; Alexandra Dürr; Paola Giunti; Caterina Mariotti; Francoise Pousset; Ludger Schöls; Pierre Vankan; Massimo Pandolfo
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

9.  The sensory neuropathy of Friedreich's ataxia: an autopsy study of a case with prolonged survival.

Authors:  S Jitpimolmard; J Small; R H King; J Geddes; P Misra; J McLaughlin; J R Muddle; M Cole; A E Harding; P K Thomas
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Friedreich's ataxia: the vicious circle hypothesis revisited.

Authors:  Aurélien Bayot; Renata Santos; Jean-Michel Camadro; Pierre Rustin
Journal:  BMC Med       Date:  2011-10-11       Impact factor: 8.775

View more
  1 in total

1.  Substantia nigra echogenicity in hereditary ataxias with and without nigrostriatal pathology: a pilot study.

Authors:  Patricia Martínez-Sánchez; Rubén Cazorla-García; Irene Sanz-Gallego; Elisa Correas-Callero; Irene Pulido-Valdeolivas; Javier Arpa
Journal:  Cerebellum       Date:  2015-06       Impact factor: 3.847

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.